Vyne Therapeutics Inc.
13F holders, Q4 2025 (December 31)43holders +10
10new positions
3sold out
1famous investor
$0.58avg. 13F price*
At the end of Q4 2025, 43 institutions reported holding Vyne Therapeutics Inc. in their 13F filings, up 10 from Q3 2025. 10 opened new positions and 3 sold out. The largest holders were Shay Capital LLC ($942K), Anson Funds Management LP ($739K) and Deeter Investments LLP ($580K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Vyne Therapeutics Inc.
- CUSIP
- 92941V308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $1.6M |
| Exits | 3 | $328K |
All 13F filers, Q3 2025 → Q4 2025: 4,499,927 shares bought and 1,690,084 shares sold, net +2,809,843 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| Shay Capital LLC | 0.15% | Add +229.8% | 1,624,349 | $942K |
| Anson Funds Management LP | 0.10% | New | 1,274,386 | $739K |
| Deeter Investments LLP | 0.13% | — | 1,000,000 | $580K |
| Nantahala Capital Management, LLC | 0.03% | New | 1,000,000 | $580K |
| T3 Companies, LLC | 0.71% | — | 945,000 | $548K |
| Acadian Asset Management LLC | 0.00% | Add +43.0% | 638,492 | $370K |
| KVP Capital Advisors, LP | 0.30% | — | 500,551 | $290K |
| Vanguard Group Inc. | 0.00% | Add +65.2% | 314,545 | $182K |
| Ikarian Capital, LLC | 0.02% | Reduce -8.7% | 264,912 | $154K |
| ADAR1 Capital Management, LLC | 0.01% | New | 253,791 | $147K |
| Geode Capital Management, LLC | 0.00% | Add +64.2% | 225,152 | $131K |
| Two Sigma Investments, LP | 0.00% | Reduce -0.4% | 220,000 | $128K |
| Two Sigma Advisers, LP | 0.00% | Add +188.2% | 163,100 | $95K |
| Susquehanna International Group, LLP | 0.00% | Add +73.7% | 100,341 | $58K |
| Rangeley Capital, LLC | 0.05% | Add +100.0% | 100,000 | $58K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -23.6% | 81,371 | $47K |
| XTX Topco Ltd | 0.00% | New | 79,040 | $46K |
| Jane Street Group, LLC | 0.00% | Reduce -50.8% | 72,356 | $42K |
| UBS Group AG | 0.00% | Add +1026.4% | 62,761 | $36K |
| Gsa Capital Partners LLP | 0.00% | Add +50.2% | 53,961 | $31K |
| BlackRock, Inc. | 0.00% | No change | 44,405 | $26K |
| Citadel Advisors | 0.00% | New | 30,526 | $18K |
| Virtu Financial LLC | 0.00% | New | 25,327 | $15K |
| FNY Investment Advisers, LLC | 0.00% | New | 25,000 | $14K |
| Northern Trust Corp. | 0.00% | No change | 23,110 | $13K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 18,298 | $11K |
| State Street Corp. | 0.00% | No change | 15,765 | $9K |
| Harvest Investment Services, LLC | 0.00% | No change | 11,059 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.8% | 3,567 | $2K |
| Royal Bank of Canada | 0.00% | Add +0.0% | 2,441 | $1K |
| Bank of America Corp. | 0.00% | Add +9.5% | 1,677 | $973 |
| Acorn Capital Advisors, LLC | 0.00% | Reduce -99.8% | 1,425 | $827 |
| Mb, Levis & Associates, LLC | 0.00% | No change | 1,041 | $604 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 800 | $464 |
| Hurley Capital, LLC | 0.00% | New | 561 | $325 |
| JPMorgan Chase & Co. | 0.00% | No change | 146 | $85 |
| Wells Fargo & Company | 0.00% | No change | 65 | $38 |
| Morgan Stanley | 0.00% | Reduce -95.3% | 43 | $25 |
| Truvestments Capital LLC | 0.00% | No change | 25 | $15 |
| NFSG Corp | 0.00% | No change | 10 | $6 |
| Cwm, LLC | 0.00% | No change | 500 | $0 |
| Centerpoint Advisors, LLC | 0.00% | No change | 350 | $0 |
| Motiv8 Investments LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is VYNE THERAPEUTICS INC's weight in each manager's 13F, not the share of Vyne Therapeutics Inc. the manager owns.